Physician profile
Mark A Pinsky
NPI 1699884510
$22,256.44
in general payments reported to CMS, 2019-2025
16 companies · $639 in 2025
The $639 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $2,405 · 2021: $482 · 2022: $5,027 · 2023: $896 · 2024: $319 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,493 · Travel and Lodging: $327 · Education: $33.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,493.30 |
| Travel and Lodging | $326.57 |
| Education | $33.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $17,812.31 | 2019-2022 | |
| Galderma Laboratories, L.P. | $2,046.97 | 2020-2024 | Dysport |
| Merz North America, INC. | $740.08 | 2019-2025 | |
| Abbvie INC. | $451.93 | 2023-2025 | |
| Biotissue Holdings INC. | $326.57 | 2025 | |
| Dilon Technologies, INC. | $295.05 | 2022-2024 | Hemoblast Bellows |
| Sientra, INC. | $113.33 | 2021 | |
| Revance Therapeutics, INC. | $101.20 | 2024 | Daxxify |
| Musculoskeletal Transplant Foundation INC. | $86.61 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $85.73 | 2021-2025 | |
| Pfizer INC. | $61.20 | 2021-2024 | |
| Acera Surgical, INC. | $51.14 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $37.14 | 2020 | |
| Mimedx Group, INC. | $17.99 | 2025 | |
| Smith+Nephew, INC. | $14.78 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $14.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.